By Reuters Staff
1 Min Read
MEXICO CITY, April 22 (Reuters) - Mexico’s antitrust authority on Thursday said it had filed a dispute in the Supreme Court against the government’s electricity reforms.
The Federal Economic Competition Commission (COFECE) said some of the changes proposed by Andres Manuel Lopez Obrador’s government prevent competition in the sector.
“It breaks the rule of open and non-discriminatory access to distribution and transmission networks, which reduces the ability to compete for certain generators and traders,” Cofece said in a statement. (Reporting by Adriana Barera; Writing by Drazen Jorgic; Editing by Frank Jack Daniel)
Mexico s anti-trust watchdog files Supreme Court case against electricity reforms reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Thursday, April 15, 2021
The Federal Economic Competition Commission (COFECE, or the Commission) has published an update to the Merger Control Guidelines. Although there are no significant changes from the prior version, the Commission did strengthen its view to carry out a “substance-over-form” analysis when it comes to transactions requiring prior antitrust clearance in Mexico.
1 Some of the key aspects include:
1.
Not only acquisitions are reportable “concentrations.”
As with competition law in other jurisdictions, Mexico’s Competition Law uses the term “concentration” to refer to those transactions that could be reportable to the Commission when meeting certain thresholds. Definition of the term “concentration” has always been an issue. The Guidelines list as examples of reportable transactions not only mergers and acquisitions but also trusts (
In this Issue:
United States
1. FTC abandons challenge to Philadelphia hospital merger.
On March 1, 2021, the FTC, suffering its first loss in a hospital merger challenge since 2016, voted 4-0 to end its effort to stop the proposed $599 million merger of Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network. The FTC’s decision comes about a month and a half after the Pennsylvania Attorney General’s office dropped out of the joint challenge.
The FTC challenged the merger on the basis that it would hurt competition in the Philadelphia-area health care market, and after a defeat at the district court, told the appellate court that the judge had applied “faulty economic reasoning.” The FTC alleged that a combined network would control over 60% of the market for inpatient general acute care services in and around North Philadelphia and at least 45% of the market for those services in and around Montgomery County. The FTC alleged that t
Thursday, April 8, 2021
Federal Trade Commission (FTC)
On March 1, 2021, the FTC, suffering its first loss in a hospital merger challenge since 2016, voted 4-0 to end its effort to stop the proposed $599 million merger of Philadelphia-area health care systems Jefferson Health and Albert Einstein Healthcare Network. The FTC’s decision comes about a month and a half after the Pennsylvania Attorney General’s office dropped out of the joint challenge.
The FTC challenged the merger on the basis that it would hurt competition in the Philadelphia-area health care market, and after a defeat at the district court, told the appellate court that the judge had applied “faulty economic reasoning.” The FTC alleged that a combined network would control over 60% of the market for inpatient general acute care services in and around North Philadelphia and at least 45% of the market for those services in and around Montgomery County. The FTC alleged that the defendants also control